Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02625935 · ClinicalTrials.gov registry record

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

A clinical trial of Breast Cancer, sponsored by NanoString Technologies.

Completed
Registry status
206
Enrollment target
4
Study locations

NCT02625935: Completed study of Breast Cancer, sponsored by NanoString Technologies.

NCT02625935 is a study of Breast Cancer that has completed, run by NanoString Technologies. The registered enrollment target is 206 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02625935, a study of Breast Cancer, has completed, sponsored by NanoString Technologies.

COMPLETED
Registry status
206 participants
Enrollment target
4
Study locations

Study Summary

This multicenter, prospectively designed study examines whether the Prosigna score influences physician and patient adjuvant treatment selection over and above currently used prognostic factors. This study also examines the impact of the test results on patients' reported outcomes, including their decisional conflict status and anxiety levels.

Conditions Studied

Breast Cancer

Study Locations (4)

Florida

  • Florida Cancer Center - Fort Myers

Maine

  • New England Cancer Specialists - Scarborough

Maryland

  • Center for Cancer and Blood Disorders - Bethesda

New York

  • North Shore Hematology Oncology Assoaciates - East Setauket

Trial Details

FieldValue
Enrollment Target 206 participants
Start Date 2015-12
Est. Completion 2017-10-10

Sponsor

NanoString Technologies

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02625935

The ClinicalTrials.gov registry entry for NCT02625935 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (93% lower). The listed sponsor is NanoString Technologies, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT02625935 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Florida, Maine, Maryland.

Frequently Asked Questions

What is clinical trial NCT02625935 about?

NCT02625935 is a clinical study titled "Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients". This multicenter, prospectively designed study examines whether the Prosigna score influences physician and patient adjuvant treatment selection over and above currently used prognostic factors. This study also examines the impact of the test results on patients' reported outcomes, including their d...

What is the current status of trial NCT02625935?

This trial is currently completed. The enrollment target is 206 participants. The study started on 2015-12. Estimated completion is 2017-10-10.

What conditions does trial NCT02625935 study?

This clinical trial studies the following conditions: Breast Cancer.

Who is sponsoring clinical trial NCT02625935?

This trial is sponsored by NanoString Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02625935 being conducted?

This trial has 4 study locations across Florida, Maine, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Breast Cancer

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.